Aimed at treating serious and life-threatening conditions that do not respond to standard prescriptions 

Riyadh:  The Chairman of the Saudi Food and Drug Authority SFDA and Minister of Health Fahad Aljalajel launched the promising medicines program in Riyadh on Sunday, December 10th.

The program ensures early access to experimental treatments for patients who fail to react to standard medications and shortens the period required for new treatments to enter the Saudi market.

Promising medications include all treatments that are safe and have completed clinical trials showing clear therapeutic effects for incurable or rare diseases or those that are highly prevalent in society.

The Saudi Food and Drug Authority SFDA has started to implement this program on an experimental basis and has achieved success in evaluating several treatments in parallel with international regulatory authorities.